Molecular Diagnostics Market Size, Share, Trends and Industry Analysis By Product Type (Instruments Reagents & Consumables), By Application (Infectious Disease, Blood Screening, Histology & Oncology), By Technique (Hospitals Amplification, Hybridization & Sequencing Techniques), End User (Hospitals, Clinical & Pathology Labs), and Regional Forecast 2025-2032

The molecular diagnostics market size was valued at USD 15.26 billion in 2024. It is projected to grow from USD 15.78 billion in 2025 to USD 21.21 billion by 2032, exhibiting a CAGR of 4.2% during 2025-2032. North America dominated the global market with a share of 45.44% in 2024.

During the last decade, molecular diagnostics has emerged as a superior methodology. It has achieved the goal of faster disease diagnosis with minimal complexities. The demand for these procedures is higher, particularly for diagnosing infectious diseases.

The growing prevalence of infectious diseases in developing and developed nations is boosting the demand for molecular diagnosis. Major viral and bacterial outbreaks in the Middle East and Africa forced all governments and research institutions across the globe to adopt molecular diagnostic techniques to inhibit microbial outbreaks. In terms of techniques, the amplification techniques segment is projected to hold a considerable share in the global market. The consumables and reagent segments are also expected to hold a considerable share in this market.

Download Free sample to learn more about this report.

Molecular Diagnostics Market Overview

Market Size:

• 2024 Value: USD 15.26 billion
• 2025 Value: USD 15.78 billion
• 2032 Forecast Value (with CAGR): USD 21.21 billion (CAGR of 4.2%)

Market Share:

• Regional Leader: North America (45.44% market share in 2024)
• Fastest-Growing Region: Asia Pacific
• End-User Leader: Infectious Disease Application (60.0% share in 2024)

Industry Trends:

• Amplification techniques dominating due to rapid and accurate results
• High demand for reagents and consumables in diagnostic procedures
• Strong collaborations between research hospitals and academic institutions

Driving Factors:

• Rising prevalence of infectious diseases in developed and developing countries
• Government reinforcement strategies and funding for microbial outbreak prevention
• WHO and World Bank-led awareness programs boosting diagnostic adoption
• Advancements in automated molecular diagnostic platforms
• Improved reimbursement frameworks are accelerating adoption in clinical settings

Key Market Drivers

Infectious Diseases are expected to drive the molecular diagnostics market growth

Managing microbial outbreaks and infections across the globe is a big challenge faced by all governments worldwide. A huge amount of resource engagement in terms of technology, expertise, and finance serves, and a favorable environment for the imitation of research projects, particularly for infectious diseases, is boosting the market for molecular diagnostics. The Infectious diseases application segment accounted for a market share of 60.0 % in 2024. Moreover, a rise in awareness programs initiated by global organizations such as the World Health Organization (WHO), the World Bank, and others for infectious diseases is expected to encourage the talent pool to step forward to achieve higher utilization of such diagnostic technologies.

Molecular Diagnostics Market Segmentation

To know how our report can help streamline your business, Speak to Analyst

Based on applications, the global molecular diagnostic market segments include infectious diseases, blood screening, histology, oncology, etc. Infectious diseases held an estimated 60.0% of the market share in 2024. The global molecular diagnostic market includes reagents and consumables based on the product type. In terms of techniques, the global molecular diagnostic market is categorized as amplification techniques, hybridization techniques, sequencing techniques, and others.

The global market includes various end users, including clinical and pathology labs, hospitals, and others (physicians’ offices, clinics, emergency centers, long-term and urgent care centers, etc.). Lucrative reimbursement strategies offered by the government for the implementation of molecular diagnostics signify considerable growth in the execution of these diagnosis systems in clinical and pathology labs and hospitals.

Regional Analysis

Reinforcement Strategies of Government Institutions for Molecular Diagnostics Reflected as Higher Growth of the Market in North America

To get more information on the regional analysis of this market, Download Free sample

North America generated USD 6.47 billion in 2024 and is anticipated to dominate the molecular diagnostics market share during the forecast period. Growth witnessed in the region is likely driven by the increasing association and collaborative efforts of large academic institutions and research hospitals. Moreover, the increasing interactions between hospital research organizations and academic institutions for process improvements will help boost the market. Utilizing a large amount of molecular diagnostics to improve clinical efficiency is projected to offer significant growth for the market during the forecast period.

Moreover, the rising emphasis on bigger hospital research and clinical microbiology organizations, and their collective efforts to increase molecular diagnostics, are expected to drive the market in Europe. Though improvements in Asia Pacific and Latin America are currently premature, rapidly developing infrastructure and increasing investments in research and development are anticipated to serve huge potential for the market growth in Asia Pacific.

Key Market Players

QIAGEN, F. Hoffmann-La Roche Ltd., Danaher Corporation, and Abbott Laboratories are Expected to Hold Considerable shares in the Global Market

Giant organizations such as QIAGEN, F. Hoffmann-La Roche Ltd., Danaher Corporation, and Abbott Laboratories are expected to lead the global market during the forecast period. Optimal research & development strategies, robust supply chain network, increasing investments in research & development, and cost management are projected to serve as huge opportunities for the aforementioned market players to lead this market during the forecast period. Moreover, higher potential for intense penetration of advanced diagnostics in the Asia Pacific market may offer a significant share for the companies in terms of revenue in the global molecular diagnostics market.

Top Molecular Diagnostic Market Players

• bioMérieux SA.
• BD
• Danaher Corporation
• Grifols, S.A.
• Hologic Inc.
• Novartis AG
• QIAGEN
• Siemens Healthcare GmbH
• F. Hoffmann-La Roche Ltd.
• Other players

KEY INDUSTRY DEVELOPMENTS:

• March 2021 – Roche and GenMark Diagnostics entered into a merger agreement for Roche to acquire GenMark completely. By acquiring the company, GenMark’s syndromic panel testing portfolio will supplement the Roche’s current molecular diagnostics portfolio.
• March 2021 - QIAGEN N.V. made an announcement of the launch of the QIAcube Connect MDx, an adaptable platform for automated sample processing to be available to molecular diagnostic laboratories in the U.S. and Canada and other markets globally.
• April 2020 – BD, a medical technology company, and BioGX Inc., a molecular diagnostics company, made an announcement of submitting the Emergency Use Authorization requests for the approval of new diagnostic test to U.S. Food and Drug Administration (FDA) which when approved will allow hospitals to screen for COVID-19 and get the results in three hours.

Report Coverage 

The science of medical diagnostics is witnessing remarkable achievements in terms of new diagnostic domains and philosophies. The popularity of molecular diagnostics is continuously increasing in life sciences due to its extensive applications, promising solutions, and methodologies for disease diagnosis on molecular level.

The molecular diagnostics market report provides both qualitative and quantitative insights on molecular diagnostics industry trends and detailed analysis of market size & growth rate for all possible segments in the market. The market is segmented into product type, application, technique, and end user. On the basis of product type, the global market is categorized into instruments and reagents & consumables.

Based on applications, the market is segmented into infectious disease, blood screening, histology, oncology, and others. Based on techniques, this market is segmented into amplification techniques, hybridization techniques, sequencing techniques, and others. Various end users covered in the report are clinical and pathology laboratories, hospitals, and others. Geographically, the market is segmented into five major regions, which are North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. These regions are further categorized into countries.

Along with this, the report analysis includes market dynamics and a competitive landscape. Various key insights provided in the report are Porter’s five forces analysis, recent advancements in molecular diagnostics, key mergers & acquisitions, and others.

To gain extensive insights into the market, Download for Customization

Molecular Diagnostic Market Segment